Skip to Content

Tumor-infiltrating lymphocytes improves PFS in metastatic melanoma

Tumor-infiltrating lymphocytes therapy has been shown to be more effective than ipilimumab in treating patients with advanced melanoma, making tumor-infiltrating lymphocytes a promising new treatment option.

Get access to the article

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top